Volume 17, Number 10—October 2011
Unexpected Rift Valley Fever Outbreak, Northern Mauritania
During September–October 2010, an unprecedented outbreak of Rift Valley fever was reported in the northern Sahelian region of Mauritania after exceptionally heavy rainfall. Camels probably played a central role in the local amplification of the virus. We describe the main clinical signs (hemorrhagic fever, icterus, and nervous symptoms) observed during the outbreak.
From late September through the beginning of October 2010, unprecedented rainfall created large ponds in the oases of the Saharan region of Adrar, northern Mauritania (Figure 1). Such rains had not been observed for decades; the local residents refer to 1956 (locally known as the “year of the fever”) to describe similar events. This climatic event translated into unusual growth of vegetation, attracting shepherds and pastoralists from remote areas, including the southern and southeastern regions of the country. It also favored high densities of mosquitoes, mainly from the genus Culex and Anopheles (Cx. quinquefasciatus, An. pharoensis, An. protoriensis, Cx. poicilipes, An. gambiae, Aedes vexans, Cx. antenatus, An. rufipes, Mansonia uniformis, An. ziemani); some of these species were known to be competent vector species for major arboviruses.
A few weeks after these rains, severe outbreaks of malaria and Rift Valley fever (RVF) were reported in several oases (graret) of the Adrar region. Notably, the first probable reportable case in livestock was in a sick dromedary camel and occurred during the last week of October 2010 in the Aoujeft area; the camel’s signs were similar to those of pasteurellosis. The herdsman slaughtered the animal before it died but delayed the cutting up of the meat because of the remote location. Subsequently, the uncooked meat was shared within the extended family, and within a few days, several people died with intestinal and hemorrhagic symptoms. Health authorities requested testing for several pathogens, including Crimean-Congo hemorrhagic fever and RVF; results were positive for RVF. Although these persons likely did not become infected through the consumption of meat (the fall in pH during meat maturation rapidly destroys the virus) (1), the virus was obviously circulating intensively in this area at that time.
Two weeks after the index case, additional cases in camels, abortion storms in small ruminants, and human deaths (hemorrhagic fever, icterus, and nervous symptoms) were reported on a massive scale. At the end of December 2010, a total of 63 cases among humans, including 13 deaths, had been officially reported, but the true number is probably much higher due to the remoteness of the affected area. Of 14 initial blood samples from camels, 7 had positive test results by real-time reverse transcription PCR; the virus was isolated from 4 of those positive samples in the Laboratoire National d’Elevage et de Recherches Vétérinaires, Dakar, Senegal. The first serologic results obtained by the central veterinary laboratory using a competitive ELISA (ID Screen Rift Valley Fever Competition Multispecies ELISA, ID-Vet, Montpellier, France) indicated an immunoglobulin (Ig) M/IgG prevalence of 33% in camels and 44% in small ruminants, respectively. IgM titers (2) were as high as 45% in Adrar and even reached 54% in the eastern Inchiri area 2 weeks after the index case in the camel was observed (Table).
Serologic evidence of RVF in camels is frequently reported (3), yet the description of clinical signs is rare (4). Some authors mention subclinical or mild forms (5) or even the capacity to carry the virus without clinical signs (1). In contrast, in the past, widespread abortion waves in camels were observed during RVF outbreaks in Kenya and Egypt and were associated with positive serologic test results (6,7). Furthermore, camels are suspected of playing a major role in the spread of RVF from northern Sudan to southern Egypt in 1977 (8). It should be noted that RVF virus was previously isolated from blood samples from healthy, naturally infected camels in Egypt and Sudan (9,10) and that experimental infections with RVF virus have induced no clinical signs in nonpregnant dromedaries (3).
During this outbreak, 2 clinical forms were observed in camels: a hyperacute form, with sudden death in <24 hours; and an acute form with fever, ataxia, ballooning, edema at the base of the neck, audible expiratory wheeze and ventral positional dyspnea, blood-tinged nasal discharge, icterus, severe conjunctivitis with ocular discharge and blindness, hemorrhages of gums and tongue, foot lesions, nervous symptoms, and abortions (Figure 2). When hemorrhagic signs developed, death usually occurred within a few days.
The current understanding of the outbreak is that the exceptional rainfall during September–October 2010 created highly favorable conditions for colonization and subsequent multiplication of competent vectors in these grarets. The virus was probably introduced rapidly through viremic animals transported by truck for grazing opportunities from various areas, including the south and southeastern regions of Mauritania where RVF is endemic (11,12). To cope with this outbreak, veterinary and public health authorities took appropriate control measures, including restriction of livestock movement, re-allocation of locust control teams for mass insecticide spraying, and risk communication and public awareness campaigns aimed at the population at risk.
We report the unusual outbreak of RVF at a northern latitude and in an extremely arid region (although RVF has been reported in Egypt, where the Nile River helps spread the disease from the south). The high mortality rates and severe clinical signs observed among dromedary camels indicate that these animals played a major role in the epidemiology of this outbreak. The capacity of RVF-infected Aedes spp. eggs to survive in such an environment also needs further assessment. Indeed, increasing capacities for long-distance transportation, associated with increasing frequencies of extreme and hard-to-predict weather events, may create a challenging scenario for exotic diseases in general, and RVF in particular, to spread.
During the course of the outbreak in Adrar, the price of livestock decreased by 40%, which created an attractive opportunity for traders who potentially could further disseminate the virus. Also, the possible role of oases as relay points has for some time been seen as a major risk for the introduction of RVF in the Maghreb, where eco-climatic and entomologic conditions are favorable for its emergence. These possible risk factors and the unusual appearance of RVF in an arid region call for further strengthening of surveillance and sanitary capacities and policies.
Dr El Mamy is the head of the Unit for Infectious diseases at the National Veterinary Laboratory in Mauritania. He has been in charge of Rift Valley fever serosurveillance and virus detection for about 10 years, including sentinel herd-based monitoring of the activity of the virus in disease-endemic areas of the country.
- Swanepoel R, Coetzer JAW. Rift Valley fever. In: Coetzer J, Tustin R, editors. Infectious diseases of livestock, 2nd ed. Oxford (UK): Oxford University Press; 2004. p. 1037–70.
- Paweska JT, Burt FJ, Anthony F, Smith SJ, Grobbelaar AA, Croft JE, IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for detection of antibody to Rift Valley fever in domestic ruminants. J Virol Methods. 2003;113:103–12.
- Davies FG, Koros J, Mbugua H. Rift Valley fever in Kenya: the presence of antibodies to the virus in camels (Camelus dromedarius). J Hyg (Lond). 1985;94:241–4.
- Bird BH, Ksiazek TG, Nichol ST, MacLachlan NJ. Rift Valley fever virus. J Am Vet Med Assoc. 2009;234:883–93.
- Peters CJ, Meegan JM. Rift Valley fever in CRC handbook series in zoonoses. In: Beran G, editor. Boca Raton (FL): CRC Press; 1981. p. 403.
- Meegan JM, Hoogstraal H, Mousa MI. An epizootic of Rift Valley fever in Egypt in 1977. Vet Rec. 1979;105:124–5.
- Scott GR, Roach RW, Cowdy NR, Coakley W. Rift Valley fever in camels. J Pathol Bacteriol. 1963;86:229–31.
- Eisa M, Obeid HMA, El Sawi ASA. Rift Valley fever in the Sudan. I—Results of field investigations of the first epizootic in Kosti District, 1973. Bull Anim Health Prod Afr. 1977;24:343–7.
- Eisa M. Rift Valley fever. OIE Technical Report Series. World Health Organization (Geneva). 1981;1:2–13.
- Imam ZEI, El-Karamany R, Darwish MA. An epidemic of Rift Valley fever in Egypt. 2. Isolation of the virus from animals. Bull World Health Organ. 1979;57:441–4.
- Thiongane Y, Martin V. Bulletin FAO de surveillance de la fièvre de la vallée du Rift en Afrique de l’Ouest (Mali, Mauritanie, Sénégal), no. 1. Rome: Food and Agricultural Organization of the United Nations; 2000.
- Zeller HG, Fontenille D, Traore-Lamizana M, Thiongane Y, Digoutte JP. Enzootic activity of Rift Valley fever virus in Senegal. Am J Trop Med Hyg. 1997;56:265–72.
- Figure 1. Lefrass Oasis, 30 km north of Atar, one of the main outbreak foci of an outbreak of Rift Valley fever in camels, northern Mauritania. Inset shows the location of...
- Figure 2. Observed clinical symptoms of Rift Valley fever in camels during field investigation in the Adrar region, northern Mauritania. A) Conjunctivitis and ocular discharge, hemorrhages of the gums, and edema...
- Table. Serologic data obtained from different regions, overall and per host species during Rift Valley Fever outbreak, northern Mauritania, September–October 2010
Suggested citation for this article: El Mamy ABO, Ould Baba M, Barry Y, Isselmou K, Dia ML, Hampate B, et al. Unexpected Rift Valley fever outbreak, Northern Mauritania. Emerg Infect Dis [serial on the Internet]. 2011 Oct [date cited]. http://dx.doi.org/10.3201/eid1710.110397
Please use the form below to submit correspondence to the authors or contact them at the following address:
Stephane de La Rocque, FAO-AGAH, Viale delle terme de Caracalla, 00153 Rome, Italy
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: September 26, 2011
- Page last updated: September 26, 2011
- Page last reviewed: September 26, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)